Here is a copy under PXS for those who follow her.
"Going away for a few days but got my bioshares latest - has a section on possible biotec M&A activity - PTD & AML discounted though possible acquirors - PXS given the most likely and PRR's sub Arthron the most likely to sell.
Wether PXS is interested I don't know - PXS punters can comment on that but I know PRR intend to flog Arthron as soon as the have maximised its potential - there are 2 deals about to drop out of it (read the last broker report) and then AstraZ news but the tyres have already been kicked as I understand it. People will be surprised at what they get for it too - my opinion (sort of).
I know it will be swamped by the bearishness out of they states while I am away but she's a jewel and it won't take much to get her to shine."
PXS Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
